📰 Pharma Corp News
Page 3 - Pharma Corp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Corp. Real-time updates on events, politics, business and more.
July 24, 2023
Equities research analysts at StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Free Report) in a research note issued to investors on Saturday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other research firms have also recently commented on CTIC. Stifel Nicolaus cut CTI BioPharma from […]
July 18, 2023
Swedish Orphan Biovitrum intends to carry out a rights issue of about 6 billion Swedish crowns , and calls for an Extraordinary General Meeting to be held on August 15, the drugmaker said in a...
July 17, 2023
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts also recently issued research reports about the stock. TD Cowen reduced their target price on shares of CTI BioPharma from $10.00 to $8.00 […]
July 17, 2023
StockNews.com initiated coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research report report published on Friday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. CTIC has been the subject of several other research reports. SVB Securities lowered shares of CTI BioPharma from an outperform rating to a […]
July 16, 2023
Research analysts at StockNews.com began coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Free Report) in a research report issued on Friday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Other research analysts have also issued reports about the company. TD Cowen lowered their price objective on CTI BioPharma from $10.00 […]
July 8, 2023
StockNews.com assumed coverage on shares of CTI BioPharma (NASDAQ:CTIC – Free Report) in a research report report published on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. CTIC has been the topic of a number of other research reports. Stifel Nicolaus cut CTI BioPharma from a buy rating to a hold […]
June 28, 2023
StockNews.com started coverage on shares of CTI BioPharma (NASDAQ:CTIC – Get Rating) in a research note released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other equities analysts have also recently commented on CTIC. Stifel Nicolaus cut shares of CTI BioPharma from a buy rating to […]
June 7, 2023
Latest Study on Industrial Growth of Genome Perturbation Tools Market 2023-2029. A detailed study accumulated to offer Latest insights about acute fea
June 2, 2023
CTI BioPharma (NASDAQ: CTIC) recently received a number of ratings updates from brokerages and research firms: 5/26/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/18/2023 – CTI BioPharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 5/16/2023 […]
June 2, 2023
CHICAGO — Fewer than half of adolescents and young adults with acute lymphoblastic leukemia received first-line treatment at a specialized cancer center, despite an association of such treatment with longer survival, study results showed.The findings, presented at ASCO Annual Meeting, also revealed independent associations of age, race/ethnicity and insurance type with odds of treatment at